Patents
Patents for C07C 323 - Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups (27,160)
08/2002
08/01/2002WO2002012190A3 Non-imidazole aryloxypiperidines as h3 receptor ligands
08/01/2002WO2002002505A3 Compounds to treat alzheimer's disease
08/01/2002US20020103399 Processes for producing B-halogeno-a-amino-carboxylic acids and phenylcysteine derivatives and intermediates thereof
08/01/2002US20020103396 Process for the preparation of 2-alkylthio benzoic acid derivatives
08/01/2002US20020103239 Such as N-hydroxy-2-(((4-phenoxyphenyl)-sulfonyl)methyl) benzamide which inhibits matrix metalloprotease activity
08/01/2002US20020103217 Triphenylpropanamide compounds; useful in treating inflammations but which do not demonstrate side effects associated with other anti-inflammatory treatments such as glucocorticoids
08/01/2002US20020103192 Perfluoroalkylketones, ketooxazoles, ketoamides, ketoesters, and diketones, and their dihydroxy derivatives, such as 7-((1,1'-biphenyl)-3-yloxy)-1-(1,3-oxazol-2-yl)-1-heptanone
08/01/2002US20020103163 Acetylenic sulfonamide thiol TACE inhibitors
08/01/2002US20020100732 For removing metals from soils, water; pollution control; form stable, irreversible ligand-metal precipitates
08/01/2002CA2735478A1 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
08/01/2002CA2735267A1 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
08/01/2002CA2435883A1 Benzylamine analogue
07/2002
07/31/2002EP1227092A2 Isonitrile intermediates for the preparation of tri-substituted imidazole compounds with multiple therapeutic properties
07/31/2002EP1227091A2 Formamide intermediates for the preparation of tri-substituted imidazole compounds with multiple therapeutic properties
07/31/2002EP1226819A1 Inhibitor for 20-hete-yielding enzyme
07/31/2002EP1226108A1 Diaryl-enynes
07/30/2002US6426424 Heating hydrated metal sulfate salt, an amino acid ligand and a reaction modifier in an enclosed environment, ligand to metal molar ratio is from 1:1-4:1
07/30/2002US6426365 CETP activity inhibitors
07/30/2002US6426364 Nervous system or psychological disorders
07/25/2002WO2002057222A2 Thiol-based naaladase inhibitors
07/25/2002WO2002057216A1 Terphenyl compounds bearing substituted amino groups
07/25/2002WO2002056880A1 Triphenylmethane kinesin inhibitors
07/25/2002WO2002030947A3 Compositions and methods of preparing amino acid chelates and complexes
07/25/2002WO2002030874A3 Aliphatic, cyclic amino carboxylic acids as integrin antagonists
07/25/2002WO2001092273A3 Benzenedicarboxylic acid derivatives
07/25/2002US20020099220 Calcilytic compounds
07/25/2002US20020099038 O- or S- substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
07/25/2002US20020098999 Compounds for sustained release of orally delivered drugs
07/25/2002US20020098148 Radiolabelled substituted carbonylaminobenzene derivatives which bind androgen recepotr
07/24/2002EP1224171A1 Beta disubstituted metalloprotease inhibitors
07/24/2002EP1224167A1 Resolution of intermediates in the synthesis of substantially pure bicalutamide
07/24/2002CN1088058C Modified polyunsaturated fatty acids
07/23/2002US6423865 Compounds and their application as well as a method of producing liquid crystalline polymers therefrom
07/23/2002US6423690 Antibacterial agents
07/23/2002US6423519 Contacting fungal cell with compound which inhibits prenyltransferase activity of cell, including permease tag which facilitates permease-mediated transport of compound into cell, inhibiting growth thereof
07/23/2002CA2042503C Novel bifunctional linking compounds, conjugates and methods for their production
07/18/2002WO2002012224A3 Bicyclic compounds as h3 receptor ligands
07/18/2002WO2002003912A3 Novel c-4 substituted retinoids
07/18/2002WO2001077072A3 Compounds and methods to increase plasma hdl cholesterol levels and improve hdl functionality
07/17/2002EP1222165A2 Methods of asymmetrically synthesizing enantiomers of casodex, its derivatives and intermediates thereof
07/17/2002EP1222159A2 Intermediates for making a benzofuran or benzothiophene derivative nitrated in position 5 and uses thereof
07/17/2002EP1222026A1 Supported ferrocene-based catalysts for selective aldehyde hydrogenation
07/17/2002EP1039902A4 Inhibitors of gap junction communication
07/17/2002EP0939629A4 Thiol sulfonamide metalloprotease inhibitors
07/17/2002CN1359373A 6[(aryl and heteroaryl)oxy] methyl] naphthalene-2-carboximidamide derivatives, preparation and therapeutic application thereof
07/17/2002CN1358712A Productive process for Rufloxaxin Hydrochloride raw material
07/16/2002US6420600 Hydroxyalkylphenyldiamides
07/16/2002US6420573 Processes for preparing 3-arylsulfur hydroxamic acids
07/16/2002US6420561 Piperazinyl or piperidinyl acid derivatives for treatment of rheumatic diseases, arthritis due to gout and antiinflammatory agents
07/16/2002US6420427 Prevention and/or treatment of rheumatoid diseases, arthrosteitis, unusual bone resorption, osteoporosis, periodontitis, interstitial nephritis, arteriosclerosis, pulmonary emphysema, cirrhosis, cornea injury
07/16/2002US6420426 Used to treat complications from diabetes mellitus
07/16/2002US6420423 Pesticides
07/16/2002US6420396 Biphenyl and biphenyl-analogous compounds as integrin antagonists
07/16/2002US6420390 Heteroarylpiperidines and their use as antipsychotics
07/16/2002US6420341 Treating vasoconstrictor and hypertension effects in warm-blooded animals
07/11/2002WO2002053624A1 Crosslinked disulphide containing polymers for drug delivery
07/11/2002WO2002053522A2 Novel estrogen receptor ligands and methods i
07/11/2002WO2002024632A3 Substituted aminopropoxyaryl derivatives useful as agonists for lxr
07/11/2002WO2001040187A3 Compound having effect of promoting neuron differentiation
07/11/2002US20020091163 Triptycene analogs
07/11/2002US20020090684 Racemization of preferential amino acids; obtain chemical intermediate, incubate with preferential enzyme, recover amino acid
07/11/2002CA2433828A1 Novel estrogen receptor ligands and methods i
07/10/2002EP1221050A2 Biomolecular attachment sites on microelectronic arrays
07/10/2002EP1220836A2 Benzylcycloalkyl amines as modulators of chemokine receptor activity
07/10/2002EP1220832A1 Novel aromatic compounds
07/10/2002EP0952975B1 Bi-aromatic compounds bound by a heteroethynylene radical and pharmaceutical and cosmetic compositions containing same
07/10/2002EP0784617B1 Substituted diphenyl oxazolines
07/10/2002CN1358171A Valency platform molecules comprising aminooxy groups
07/10/2002CN1357536A Linking molecule for selective metallation of nucleic acid and its application
07/10/2002CN1087287C Antioxidants containing phenol groups and aromatic amine groups
07/10/2002CN1087285C Basic group substituted benzoyl guaniazine, its preparing process, its use as medicine or diagnostic reagent, and medicine containing the same
07/09/2002US6417395 Hydrating methionine aminonitrile to methioninamide using ketone and basic resin catalysts
07/09/2002US6417387 α-and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
07/09/2002US6417386 Hydrazone derivatives; acarina; miticides
07/09/2002US6417370 Arylphenyl-substituted cyclic keto-enols
07/09/2002US6417357 Coupling reactions with palladium catalysts
07/09/2002US6417232 Fatty acid analogues for the treatment of primary and secondary restenosis
07/09/2002US6417223 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses therof
07/09/2002US6417009 Reservoir components
07/09/2002CA2217455C New substituted derivatives, of biphenyl or phenylpiridine, their preparation process and the pharmaceutical compositions that contain them
07/09/2002CA2133218C Phenyl substituted cycloalkyl hydroxyurea derivatives which inhibit lipoxygenase
07/09/2002CA2094137C Novel hydroxamic acid and n-hydroxyurea derivatives and their use
07/09/2002CA2048212C Sulfonamide derivatives
07/04/2002WO2002051983A2 Novel compounds and compositions as cathepsin inhibitors
07/04/2002WO2002051793A1 Sterol isomerase inhibitors
07/04/2002WO2002051397A1 Aniline derivatives or salts thereof and cytokine production inhibitors containing the same
07/04/2002WO2002032856A3 Insecticidal 1,8-naphthalenedicarboxamides
07/04/2002WO2002022627A3 Ligands for metabotropic glutamate receptors
07/04/2002US20020086996 N-cyanomethyl amides which are cysteine protease inhibitors; treating osteoporosis; mixtures with bisphosphonates
07/04/2002US20020086902 Process for the preparation of N-(substituted phenyl)-3-alkyl-,aryl- and heteroarylsulfonyl-2-hydroxy-2-alkyl-and haloalkylpropanamide compounds
07/04/2002US20020086887 N-Acylsulfonamide apoptosis promoters
07/04/2002US20020086815 Cancer therapy; for skin cancer, myeloids
07/04/2002CA2433520A1 Novel compounds and compositions as cathepsin inhibitors
07/03/2002EP1220024A2 Silver halide photographic element
07/03/2002EP1219598A1 Phenolic compounds and recording materials containing the same
07/03/2002EP1219595A1 O-anisamide derivatives
07/03/2002EP1218366A2 Method for producing cox-2 inhibitors
07/03/2002EP1218333A1 Anti-inflammatory nitro- and thia- fatty acids
07/03/2002EP1218000A1 Anti-cancer nitro- and thia-fatty acids
07/03/2002EP0968202B1 Process for preparing photoactive coumarin dervatives